| Name | Title | Contact Details |
|---|
Sanderling Ventures is one of the leading companies in the Financial Services sector.
Established in 1914, Boenning & Scattergood, Inc. is one of the oldest independent securities, asset management and investment banking firms in the region.
AMX is an institutional platform that gives investors and asset managers a way to do business with each other. It is built with fund infrastructure that`s designed for the needs of institutional investors and is managed by an 80-strong team who negotiate with managers, transition assets, provide reporting and add an extra layer of risk oversight. The platform is accessed by a portal that allows investors and managers to interact with each other. Every fund and contract on AMX is structured in a standard way which helps standardise, centralise and streamline the process so it works better for everyone. Managers access greater volume, while investors access greater purchasing power, so both enjoy the benefits of scale.
Arctaris Impact Investors, LLC is a Boston-based impact investment firm with experience spanning more than 11 years, 6 funds, and both debt and equity investments. Arctaris invests in growth-oriented operating businesses and community infrastructure projects located in Opportunity Zones and other underserved communities. Arctaris utilizes an innovative capital structure, blending public capital from federal and state government agencies with private capital from institutional investors, foundations, and CRA banks. As a result, each of Arctaris` funds is designed to provide attractive returns along with the benefit of principal-protection, while also spurring economic development in underserved communities. In 2018, Arctaris launched its 4th fund, the Arctaris Impact Fund, LP, which aims to originate $500m of growth capital investments to businesses in underserved regions with an emphasis on inner cities and targeted rural communities. The Impact Fund`s structure is designed to provide above-market returns, liquidity, principal-protection, and CRA credit (for bank investors), while revitalizing underserved communities. The Fund includes significant principal-protection through foundations and government partners. In 2019, Arctaris launched its 5th fund, the Arctaris Opportunity Zone Fund 2019, LLC, which received significant allocation and principal guarantees from the Kresge Foundation, the State of Maine, and other government economic development agency partners. And in 2020, Arctaris launched its 6th fund, the Arctaris Opportunity Zone Fund 2020, LLC, which builds on the success of the 2019 Opportunity Zone Fund in underserved communities throughout the U.S.
RA Capital Management (“RA Capital”) is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with minimal capital concerns from inception through commercialization. RA Capital`s scientifically trained research team is intensely data driven in its continual effort to identify early breakthroughs and originate conviction in new ideas. The team`s understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability.